Aim: Aim: The aim is to review and discuss the strategies available for use of platelet rich fibrin as healing aid in dentistry.
INTRODUCTION
Development of the bioactive surgical additives is one of the great challenges of clinical research which has been used to regulate inflammation and increase the speed of healing process. [1] A wide range of intra-and extraarticular events and various signaling proteins mediate and regulate the healing process of both hard and soft tissues, respectively. But understanding this entire process is still incomplete; however, it is known that platelets play a crucial role not only in hemostasis, but also in the wound healing process. [2] In 1974, platelets regenerative potentiality was introduced, and Ross et al., [3] were first to describe a growth factor from platelets. After activation of the platelets which are trapped within fibrin matrix, growth factors released and stimulate the mitogenic response in the bone periosteum during normal wound healing for repair of the bone. [4] Better understanding of physiologic properties of platelets in wound healing since last two decades led to increase its therapeutic applications in the various forms showing varying results.
MATERIALS AND METHODS
Structured electronic search of scientific papers published up to 15 th March 2013 was carried out on the (http://www. ncbi.nlm.nih.gov/pubmed) entire PubMed database with a custom range of 5 years and hand search for term "platelet rich fibrin" (PRF); which was further filtered using Boolean operators (AND, OR, NOT) and combination of specific keywords as following: "Platelet rich fibrin Choukroun", "platelet rich fibrin in dentistry", "platelet rich fibrin dental", "platelet rich fibrin in maxillofacial surgery", "platelet rich fibrin implant", "platelet rich fibrin periodontal", "platelet rich fibrin extraction", and "platelet rich fibrin oral"; abstracts of all relevant papers were thoroughly scrutinized and in the end and articles pertaining to the topic (PRF) were included. rich fibrin" in common dental textbooks and for additional information bibliographies of papers and review articles together with appropriate peer reviewed journals were also scrutinized. The inclusion criteria set for this review were: All case reports, case series, original research papers, review papers, in vitro/in vivo studies, animal studies, and controlled clinical trials on PRF used in dentistry related studies. Exclusion criteria consisted of studies that did not meet the above inclusion criteria.
The electronic search yielded 302 papers, out of which 72 were identified as suitable papers to the inclusion criteria and the remaining 230 were excluded [ Figure 1 ]. Only 75 papers selected, 72 from electronic search and three from other searches and full text of all articles retrieved and reviewed [ Table 1 ], out of which 22 in vivo studies, 13 in vitro studies, 14 case reports, 11 animal studies, six controlled clinical trials, two combined in vivo and in vitro studies, and seven reviews [ Figure 2 ].
PLATELET CONCENTRATE EVOLUTION
Platelets isolated from the peripheral blood acts as autologous source of growth factors. In general medical practice, platelet concentrate which is derived from blood can be used for the prevention and treatment of bleeding due to conditions like severe thrombocytopenia, severe oral hemorrhage associated with medullary aplasia, acute leukemia, etc. [5] The use of fibrin adhesives helps to initiate the development of platelet concentrate as a bioactive surgical additive. Several components in blood has been recognized since 1990, which are a part of the natural healing process and have the potential to accelerate wound healing when added to wounded tissues or surgical sites. In 1970, fibrin glue formed by polymerizing fibrinogen with thrombin and calcium was first described. Actually, it was prepared using donor plasma; but the stability and quality of fibrin glue was low because of low concentration 
Conclusion/result
Gassling et al. [20] 2013 Mar In vitro Metabolic activity and proliferation of human osteoblast cells in vitro were supported to a significant higher extent by eluates from PRF membranes. Proliferation was significantly higher on PRF membranes and PRF clot than on Bio-Gide ® membranes Keyhan et al. [21] 2013 Mar A double-blinded prospective clinical trial
Combination of fat and PRF is more effective than the combination of fat and PRP in the context of facial lipostructure surgery
Gassling et al. [22] 2013 Jan
In vivo
Within the limits of study, coverage of lateral sinus window with two different absorbable membranes (PRF or a conventional collagen membrane), Bio-Gide ® has been shown to result in a similar amount of vital bone formation and residual bone substitute Pradeep et al. [23] 2012 Dec
In vivo Within the limit of present study, there was similar PD (probing depth) reduction, CAL (clinical attachment level) gain, and bone fill at sites treated with PRF or PRP with conventional open flap debridement. Since PRF is less time consuming and less technique sensitive, it may seem a better treatment option than PRP Vinaya Kumar et al. [24] 2012 Nov Review This second generation platelet concentrate called platelet rich fibrin (PRF), has been widely used to accelerate soft and hard tissue healing. Its advantages over better known PRP includes ease of preparation/application, minimal expense, and lack of biochemical modification (no bovine thrombin or anticoagulant is required) Ozdemir et al. [25] 2012 Nov Animal study When used in conjunction with titanium barriers, PRF use can increase the quality of newly formed bone and enhance the rate of bone formation due to concentration of growth factors Yang et al. [26] 2012 Nov
Animal study This study demonstrated using autogenic cell transplantation in a porcine model, that dental bud cells (DBCs) seeded into fibrin glue-PRF could regenerate a complete tooth Shivashankar et al. [27] 2012 Oct Case report On the basis of the results obtained in our case report we conclude that revitalization of necrotic-infected immature tooth is possible under conditions of total canal disinfection and PRF is an ideal biomaterial for pulp-dentin complex regeneration Kocyigit et al. [28] 2012 Sep
Case report This clinical report presents a successful reconstruction of a severe anterior mandibular alveolar bony defect using symphysis graft and PRF Bambal et al. [29] 2012 Sep-Oct Case report This case report describes the successful use of PRF in treating periapical lesion showing better healing than the other site. This was confirmed with a 3-D X-ray Bains et al. [30] 2012 Sep Case report Histological events and reaction of mineral trioxide aggregate (MTA) with PRF is not studied so far, however, the autologous and biocompatible nature of components used for present treatment modalities seems to be beneficial for long-term clinical results Tunalı et al. [31] 2012 Aug Animal study (Titanium tubes) T-PRF could induce the formation of new bone with new connective tissue in a rabbit model of wound healing within 30 days of treatment Lekovic et al. [32] 2012 Aug
The results of this study indicate that PRF can improve clinical parameters associated with human intrabony periodontal defects and BPBM (bovine porous bone mineral) has the ability to augment effects of PRF in reducing pocket depth, improving clinical attachment levels, and promoting defect fill Wu et al. [33] 
Jun
In vitro PRF is capable of increasing osteoblast attachment, proliferation, and simultaneously upregulating collagen-related protein production. These actions in combination would effectively promote bone regeneration
Contd... 
Conclusion/result
Bielecki et al. [34] 2012 Jun Review In the four families of platelet concentrates, two families contain significant concentrations of leukocytes: Leukocyte PRP (L-PRP) and L-PRF. The presence of leukocytes has a great impact on biology of these products, not only because of their immune and antibacterial properties, but also because they are turntables of the wound healing process and the local factor regulation Del Corso et al. [35] 2012 Jun Review The use of L-PRF also allowed defining new therapeutic principles: Natural tissue regeneration (NTR) for the treatment of periodontal intrabony lesions and natural bone regeneration (NBR) for the reconstruction of alveolar ridges Simonpieri et al. [36] 2012 Jun Review PRPs failed to prove strong strategic advantages that could justify their use in daily practice and use of most PRP techniques will probably be limited to some very specific applications where satisfactory results have been reached. Only a few simple, inexpensive, and efficient techniques such as L-PRF will continue to develop in oral and maxillofacial surgery in the next years Zhang et al. [37] 2012 Jun
In vivo This preliminary study results demonstrated neither an advantage nor disadvantage of the application of PRF in combination with deproteinized bovine bone mineral in sinus augmentation after a healing period of 6 months Douglas et al. [38] 2012 May
In vitro Hydrogel biomaterials such as PRF can be mineralized through functionalization with alkaline phosphatase (ALP) Kim et al. [39] 2012 May
Animal study The PRF-mixed tricalcium phosphate (TCP) showed more rapid bone healing than the (recombinant human bone morphogenic protein 2) rhBMP-2-coated TCP or the TCP-only control Jankovic et al. [40] 2012 Apr Randomized controlled clinical study
Use of a PRF membrane in gingival recession treatment provided acceptable clinical results, followed by enhanced wound healing and decreased subjective patient discomfort compared to connective tissue graft (CTG)-treated gingival recessions Rudagi et al. [41] 2012 Apr
Case report This case report presents the successful healing and apexification with combined use of MTA as an apical barrier and autologous PRF membrane as an internal matrix Del Corso et al. [42] 2012 Apr
Case report Successful use of leukocyte-PRF during immediate postextractive implantation and loading for esthetic replacement of a fractured maxillary central incisor with promising results Lee et al. [43] 2012 Apr Animal study In the animal model, peri-implant defect sized 3.0×5.0 mm (width×length) was successfully repaired by the application of PRF alone Mendonça-Caridad et al. [44] 2012 Mar
In vivo The application of an autogenous platelet rich/fibrin rich composite matrix in tissue regeneration and wound healing has resulted in a favorable outcome, with no complications or sequelae, in a series of ten patients with advanced frontal sinus disease over a long period of time Pradeep et al. [45] 2012 Mar Randomized control clinical trial Porous hydroxyapatite (HA) when added to PRF increases the regenerative effects observed with PRF in treatment of human three wall intrabony defects Anitua et al. [46] 2012 Mar In vivo Practically, plasma rich in growth factors (PRGF) may present a role in reducing tissue inflammation after surgery, increasing new bone formation, and promoting vascularization of bone tissue Peck et al. [47] 2012 Mar Case report L-PRF is a newly developed platelet concentrate that has successfully been used in a number of surgical procedures to optimize wound healing and was used to stimulate bone formation to facilitate ideal placement of implants Clipet et al. [48] 2012 Feb
In vitro PRF conditioned medium induced gene expression in osteoblasts. Expression of osteopontin and osteocalcin and late osteogenic markers was observed and confirmed PRF is useful in stimulating tissue healing and bone regeneration Jayalakshmi et al. [49] 2012
Case report Combined use of PRF and b-tricalcium phosphate (b-TCP) for bone augmentation in treatment of periapical defects is a potential treatment alternative for faster healing than using these biomaterials alone Tatullo et al. [50] 2012
In vivo The use of PRF and piezosurgery reduced the healing time, compared to 150 days described in literature, favoring optimal bone regeneration. At 106 days, it is already possible to achieve good primary stability of endosseous implants, though lacking of functional loading Vijayalakshmi et al. [51] 2012 Jan
Case report Describes application of PRF along with bone graft and guided tissue regeneration (GTR) membrane in the treatment of fenestration defect around an implant Chang et al. [52] 2011 Dec
In vitro and in vivo
The enhancement of phosphorylated extracellular signal-regulated protein kinase (p-ERK), osteoprotegerin (OPG), and alkaline phosphatase (ALP) activity expression by PRF may provide benefits for periodontal regeneration. Clinical and radiologic analysis showed that use of PRF is an effective modality for periodontal infrabony defects Taschieri et al. [53] 2011 Dec
In vivo A modified osteotome sinus floor elevation technique with immediate postextraction implant placement and adjunct of a platelet-derived fibrin plug is a viable option for rehabilitation of fresh postextraction maxillary premolar sockets Sammartino et al. [54] 2011 Dec
In vivo Use of L-PRF as a safe filling and hemostatic material is a reliable therapeutic option to avoid significant bleeding after dental extractions without suspension of continuous oral anticoagulant therapy in heart surgery patients [56] 2011 Nov
In vitro and in vivo wound studies PRF matrix (PRFM) effectively induced endothelial cell proliferation and improved wound angiogenesis in chronic wounds, providing evidence of probable mechanisms of action of PRFM in healing of chronic ulcers Thorat et al. [57] 2011 Oct Controlled clinical trial
Within the limit of the present study, there was greater reduction in PD, more clinical attachment level (CAL) gain, and greater intrabony defect fill at sites treated with PRF than the open flap debridement alone Sharma et al. [58] 2011 Oct Randomized controlled clinical trial
Within the limitation of this study, significant improvement with autologous PRF implies its role as a regenerative material in treatment of furcation defects Ruga et al. [59] 2011 Sep Prospective, in vivo study
Combined action of PRF and piezoelectric surgery can be considered a safe and fine technique for third molar surgery and alveolar socket healing Kim et al. [60] 2011 Aug
Animal study The PRF-mixed TCP showed more rapid bone healing than the rhBMP-2-coated TCP or the TCP-only control in study of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and PRF-mixed tricalcium phosphate in rabbits Lee et al. [61] 2011 Jul
Animal study In the animal model, peri-implant defect sized 3.0×5.0 mm (width×length) was successfully repaired by the application of PRF alone Simon et al. [62] 2011 Jun
In vivo Advantages of PRFM alone includes less surgical time, elimination of techniques and potential healing difficulties associated with membranes, and less resorption during healing; as compared to guided bone regeneration procedures Prakash et al. [63] 2011 Mar Review As with PRF, though this biomaterial appears to accelerate physiologic healing, the numerous perspectives of PRF have still to be clinically tested Simonpieri A et al. [64] 2011 Feb
In vivo The use of L-PRF as sole filling material during simultaneous sinus-lift and implantation seems to be a reliable surgical option promoting natural bone regeneration Kang et al. [65] 2011 Feb
In vitro PRF as a bioscaffold and reservoir of growth factors for tissue regeneration Peck et al. [66] 2011
Case report Successful usage of L-PRF in an alveolar ridge preservation (ARP) procedure, causing improvement of wound healing and stimulation of bone formation to facilitate implant placement in a compromised extraction socket Liao et al. [67] 2011 Jan Animal study Autologous PRFG plus osteoinduced mesenchymal stem cells (MSCs) have good potential for bone regeneration. In combination with MEDPOR as GTR, bone regeneration is enhanced by preventing soft tissue in growth hindering bone regeneration Kathuria et al. [68] 2011
Case report Faster periradicular healing and complete resolution of symptoms occurred with combined use of MTA and PRF membrane as an apical barrier Toffler et al. [69] 2010 Oct
In vivo The PRF membrane or plug, also provides protection for sinus membrane during use of an osteotome; and in case of perforation, the fibrin matrix can aid in wound closure. Early review of the Osteotome-Mediated Sinus Floor Elevation (OMSFE) with PRF technique presented for localized sinus floor elevation and implant placement demonstrates a high degree of safety and success at sites with 5-8 mm residual subantral bone height Chang et al. [70] 
Oct
In vitro PRF can stimulate osteoblasts proliferation. The activation of p-ERK and OPG expression by PRF suggests a potential role for new bone formation. The application of PRF may provide benefit for bone regeneration Ari et al. [71] 2010
Case report PRF as potent bone fill in treating intrabony defects combined with endodontic lesion Huang et al. [72] 
In vitro PRF was demonstrated to stimulate cell proliferation and differentiation of dental pulp cells (DPCs) by upregulating OPG and ALP expression. These findings might serve as a basis for preclinical studies that address the role of PRF in reparative dentin formation Jang et al. [73] 2010 Jun Animal study A peri-implant defect can be successfully repaired by the application of Choukroun PRF and silk fibroin powder Gassling et al. [4] 
May
In vitro PRF appears to be superior to collagen (Bio-Gide) as a scaffold for human periosteal cell proliferation. PRF membranes are suitable for in vitro cultivation of periosteal cells for bone tissue engineering Gürbüzer et al. [74] 2010 May
In vivo case study with scintigraphic evaluation PRF might not lead to enhanced bone healing in soft tissue impacted mandibular third molar extraction sockets 4 weeks after surgery. PRF exhibits the potential characteristics of an autologous fibrin matrix. However, whether the presence of crystal-like particles on the outer surface of PRF alters bone healing should be investigated further Dohan Ehrenfest et al. [75] 
Mar
In vitro The combination of human oral bone mesenchymal stem cells (BMSC) and PRF might offer many potential clinical and biotechnological applications, and deserves new studies Picardi et al. [76] 
Feb
In vivo Platelet gel as a safe and effective therapeutic tool to support the management of skin and mucosal ulcers related to graft versus host disease (GVHD) Aleksić et al. [77] 2010 Jan-Feb In vivo
The utilization of PRF resulted in a decreased postoperative discomfort and advanced tissue healing Contd... 
Conclusion/result
Mazor et al. [12] 2009 Dec In vivo From a radiologic and histologic point of view at 6 months after surgery, the use of PRF as sole filling material during a simultaneous sinus lift and implantation stabilized a high volume of natural regenerated bone in subsinus cavity up to the tip of implants. Choukroun's PRF is a simple and inexpensive biomaterial and its systematic use during a sinus lift seems a relevant option, particularly for the protection of the Schneiderian membrane Sclafaniet al. [78] 2009 Nov Review A novel, simple method of preparing an autologous platelet derivative (Selphyl; Aesthetic Factors, Princeton, NJ) allows rapid and inexpensive generation of a PRFM that can be used to enhance healing after facial procedures as well as to rejuvenate the face without tissue manipulation He et al. [79] 2009 Nov Animal study PRF released autologous growth factors gradually and expressed stronger and more durable effect on proliferation and differentiation of rat osteoblasts than PRP in vitro Kfir et al. [80] 2009 Oct
In vivo Successful application of minimally invasive antral membrane balloon elevation (MIAMBE) with injected PRF and bone substitutes under antral membrane as alternative to the currently employed methods of maxillary bone augmentation Dohan Ehrenfest et al. [81] 2009 Sep
In vitro Cultures with PRF are always cocultures with leukocytes. These "chaperone leukocytes" could be the source of differential geographic regulation within the culture and explain double contradictory effect proliferation/differentiation observed on osteoblasts Gassling et al. [2] 2009 Jul
In vitro PRP application in cell cultures leads to higher levels of growth factors than PRF application Su et al. [82] 2009 Jul
In vitro The PRF membrane should be used immediately after formation to maximize release of GF to surgical site. The remaining fluid can be recovered as an additional source of GF for grafting Simonpieri et al. [14] 2009 Jun
In vivo PRF membranes are particularly helpful for periosteum healing and maturation. The thick peri-implant gingival is as a result of several healing phases on a PRF membrane layer Simon et al. [83] 2009 May Animal study PRFM alone may be the best graft for ridge preservation procedures Simonpieri et al. [13] 2009 Apr
In vivo PRF membranes protects the surgical site, promotes soft tissue healing, and when its fragments mixed with graft material it functions as a "biological connector" Magremanne et al. [84] 2009 Apr Case report PRF may induce healing of non-reossified cystic cavity by supplying local growth factors
Aroca et al. [19] 2009 Feb In vivo Modified coronally advanced flap (MCAF) is a predictable treatment for multiple adjacent Miller Class I or II recession-type defects. The addition of a PRF membrane positioned under the MCAF provided inferior root coverage, but an additional gain in gingival/mucosal thickness (GTH) at 6 months compared to conventional therapy Anilkumar et al. [17] 2009 Jan Case report Described laterally displaced flap technique with PRF membrane technique as a navel root coverage approach for gingival recession of the mandibular anterior teeth Diss et al. [85] 2008 May
In vivo The bone-added osteotome sinus floor elevation (BAOSFE) procedure with PRF as grafting material can lead to an endosinus bone gain Lundquist et al. [86] 2008 May Review PRF provides sustained release and protection against proteolytic degradation of endogenous fibrogenic factors important for wound healing Choukroun et al. [87] 2006
In vitro PRF as healing biomaterial PRF: Platelet rich fibrin of fibrinogen in plasma. These fibrin adhesives can be derived autologously from the patient or can be obtained commercially, but with a small risk of disease transmission for the latter one.
PLATELET RICH PLASMA
It has been shown in several studies that bone regenerative procedures may be enhanced by the addition of specific growth factors. [6] platelet rich plasma (PRP) was used as a method of introducing concentrated growth factors platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-), and insulin-like growth factor 1 (IGF-1) to the surgical site, thereby enriching the natural blood clot in order to hasten wound healing and stimulate bone regeneration. [7] A natural human blood clot consists of 95% red blood cells (RBCs), 5% platelets, less than 1% white blood cells (WBCs), and numerous amounts of fibrin strands. A PRP blood clot, on the other hand, contains 4% RBCs, 95% platelets, and 1% WBCs. [6] The PRP preparation protocol requires collection of blood with anticoagulant, centrifugation in two steps, and induced polymerization of the platelet concentrate using calcium chloride and bovine thrombin. [8] PRP has been used in conjunction with different grafting materials in bone augmentation procedures since the day of its introduction; the results from these studies are controversial and no conclusions can be drawn regarding the bone regenerative effect of PRP till date.
PRF
PRF represents a new revolutionary step in the platelet gel therapeutic concept. [1] Unlike other platelet concentrates, this technique does not require any gelifying agent, but not more than centrifugation of the natural blood without additives. [8] Choukroun et al., [9] to accumulate platelets and released cytokines in a fibrin clot. Actually the platelets and leukocyte cytokines are important part in role play of this biomaterial, but the fibrin matrix supporting them is very helpful in constituting the determining elements responsible for real therapeutic potential of PRF. [1] Cytokines are immediately used and destroyed in a healing wound. The harmony between cytokines and their supporting fibrin matrix has much more unique importance than any other constant. A fibrin glue, enriched with cytokines (such as PRP) with large uncontrollable and short-term effect is less better than a physiologic fibrin matrix (such as PRF) with good and better effects.
ADVANTAGES OF PRF OVER PRP
No biochemical handling of blood. [15] Simplified and cost-effective process. [15] Use of bovine thrombin and anticoagulants not required. [15] Favorable healing due to slow polymerization. [15] More efficient cell migration and proliferation. [15] PRF has supportive effect on immune system. [15] PRF helps in hemostasis. [15] 
PREPARATION OF PRF
The protocol for PRF preparation is very simple and simulates that of PRP. It includes collection of whole venous blood (around 5 ml) in each of the two sterile vacutainer tubes (6 ml) without anticoagulant and the vacutainer tubes are then placed in a centrifugal machine [ Figure 3 ] at 3,000 revolutions per minute (rpm) for 10 min, after which it settles into the following three layers: Upper straw-colored acellular plasma, red-colored lower fraction containing red blood cells (RBCs), and the middle fraction containing the fibrin clot [ Figure 4 ]. The upper straw-colored layer is then removed and middle fraction is collected, 2 mm below to the lower dividing line, which is the PRF [ Figure 5 ]. The mechanism involved in this is; the fibrinogen concentrated in upper part of the tube, combines with circulating thrombin due to centrifugation to form fibrin. A fibrin clot is then formed in the middle between the red corpuscles at bottom and acellular plasma at the top. The middle part is platelets trapped massively in fibrin meshes. The success of this technique entirely depends on time gap between the blood collection and its transfer to the centrifuge and it should be done in less time. The blood sample without anticoagulant, starts to coagulate almost immediately upon contact with the glass, and it decreases the time of centrifugation to concentrate fibrinogen. Following proper protocol and quick handling is the only way to obtain a clinically usable PRF clot charged with serum and platelets. Resistant autologous fibrin membranes may be available by driving out the fluids trapped in fibrin matrix. 
CLINICAL APPLICATION
Choukroun et al., [9] are well known for using autologous PRF protocol in oral and maxillofacial surgery to improve bone healing in implant dentistry. [9] The most common encountered problems are lack of adequate bone and proximity to anatomic structures at the implantation site and recent advancements of PRF usage in surgical procedures can predictably combat such difficulties.
Choukroun et al., [11] attempted to evaluate the potential of PRF in combination with freeze-dried bone allograft (FDBA) in sinus floor elevation to enhance bone regeneration and nine sinus floor augmentations were performed. Out of nine; in six sites, FDBA with PRF (test group), and in three sites FDBA without PRF (control group) was used. After 4 months, the test group and for the control group after 8 months; bone specimens from the augmented region during the implant insertion procedure were harvested and evaluated. After 4 months of healing time, histologic maturation of the test group appears to be identical to that of the control group which was for a period of 8 months with equivalent quantities for both protocols. [11] In various bone reconstruction procedures Choukroun's PRF could provide a possible new bone. Mazor et al., [12] stated that use of PRF as the sole filling material during a simultaneous sinus lift and implantation procedure had stabilized a good amount of regenerated bone in the subsinus cavity up to the tip of implants in a case series through a radiological and histological evaluation at after 6 months from the surgery. [12] Also they advocated that Choukroun's PRF, which is a simple and inexpensive biomaterial in systematic use during a sinus lift seems as an acceptable option. [12] Simonpieri et al., [13, 14] reported and confirmed the validate usage of PRF membranes in reconstruction protocols along with FDBA, 0.5% metronidazole solution in about 20 patients who were treated using this new technique and followed-up during 1-5 years, and finally 184 dental implants were placed and they found no implant or graft loss in a case series. [13] PRF membranes protects the surgical site; promotes soft tissue healing; and when its fragments mixes with graft material, it functions as a "biological connector" between the different elements of graft and acts as a matrix which supports neoangiogenesis, capture of stem cells, and migration of osteoprogenitor cells to the center of graft. [14] PRF plugs can also be used in treating the residual extraction sockets. [15] Use of autologous PRF in extracted socket filling after immediate bone augmentation using titanium membranes applied to the socket walls and primary closure was found to be feasible and safe with adequate bone filling after 8 weeks or above for implant fixation. [16] Anilkumar et al., [17] has reported PRF as a potential novel root coverage approach for treating gingival recession in mandibular anterior teeth using combined laterally positioned flap technique and PRF membrane. [17] Combined use of PRF and bone graft with good results has also been reported for combined periodontic-endodontic furcation defect. [18] Aroca et al., [19] in the 6 month of their randomized clinical trial, concluded that addition of a PRF membrane positioned under the MCAF (modified coronally advanced flap) provided inferior root coverage, but an additional gain in gingival/mucosal thickness (GTH) at 6 months compared to conventional therapy [ Table 1 ]. [19] DISCUSSION PRF first described byChoukroun et al., [9] is a new second generation of platelet concentrate. Simplified processing technique without any complex handling makes it superior to PRP. PRF can be used to promote wound healing, bone regeneration, graft stabilization, wound sealing, and hemostasis. Because the fibrin matrix is better organized, it is able to more efficiently direct stem cell migration and [88] proved a slower release of growth factors from PRF than PRP and observed better healing properties with PRF. It was observed and shown that the cells are able to migrate from fibrin scaffold; while some authors demonstrated the PRF as a supportive matrix for bone morphogenetic protein as well.
CONCLUSION
Although PRF belongs to a new generation of platelet concentrates, the biologic activity of fibrin molecule is enough in itself to account for significant cicatricial capacity of the PRF. The slow polymerization mode confers to PRF membrane as a particularly favorable physiologic architecture to support the healing process.
However, it is now necessary to look further into platelet and inflammatory features of this biomaterial. Only a perfect understanding of its components and their significance will enable us to comprehend the clinical results obtained and subsequently extend the fields of therapeutic application of this protocol.
